国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
1 071例利巴韦林不良反应/事件分析
Analysis of 1 071 Reports of ADR/ADE Induced by Ribavirin
  
DOI:
中文关键词:  利巴韦林  药品不良反应/事件  过敏样反应  安全用药
英文关键词:Ribavirin  Adverse drug reaction/event  Allergic reactions  Safe medication
基金项目:
作者单位
郭洁茹1 张锦文1 赵丽2 1.华中科技大学同济医学院附属同济医院药学部武汉4300302.湖北省药品(医疗器械)不良反应监测中心 
摘要点击次数: 659
全文下载次数: 470
中文摘要:
      摘 要 目的:分析利巴韦林不良反应/事件(ADR/ADE)发生的一般规律和特点,为临床安全用药提供依据。方法:采用回顾性研究方法,对2006年6月~2018年6月湖北省药品(医疗器械)ADR监测中心数据库中收集的1 071例利巴韦林ADR/ADE报告的患者人口学特征、用药原因、联合用药情况和不良反应受累系统/器官分布及临床表现等进行统计和分析。结果:利巴韦林引起的ADR/ADE涉及7种剂型,注射液占比最多(84.12%);ADR/ADE在各年龄组段均有分布,男性略多于女性;所致ADR/ADE临床表现复杂多样,但主要为皮疹和过敏样反应,严重者可出现过敏性休克和血液系统损害。 结论:利巴韦林致ADR/ADE个体差异大,临床用药时应严格掌握适应证,尽量避免不合理的联合用药,以减少ADR/ADE的发生。
英文摘要:
      ABSTRACT Objective: To study the general rules and characteristics of adverse drug reaction/event (ADR/ADE) induced by ribavirin and to provide references for clinical rational use of the drugs. Methods:1 071 cases of ADR/ADE related to the ribavirin from June 2006 to June 2018 in Hubei province were analyzed using retrospective study method. The demographic characteristic, drug use reasons, drug combination, adverse reaction involved organ system distribution and clinical manifestation were analyzed. Results:The ADRs/ADEs involved seven kinds of dosage forms, the injections accounted for the largest proportion (84.12%). The ADRs/ADEs occurred in all age groups, and there were slightly more male than female patients. The ADR/ADE clinical manifestations were complicated and diversified, but chiefly characterized by rash and allergic reactions, or even anaphylactic shock and damage of the blood system in serious cases. Conclusion:Adverse reactions of ribavirin were correlated with individual differences, strictly controlled the indications and avoided unreasonable drug combinations, in order to reduce the incidence of ADR/ADE.
查看全文  查看/发表评论  下载PDF阅读器
关闭